Short Interest in China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Declines By 95.0%

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) was the recipient of a large decline in short interest in February. As of February 15th, there was short interest totalling 4,700 shares, a decline of 95.0% from the January 31st total of 94,100 shares. Based on an average daily volume of 172,200 shares, the short-interest ratio is currently 0.0 days.

China SXT Pharmaceuticals Trading Up 0.2 %

Shares of China SXT Pharmaceuticals stock traded up $0.01 during trading on Friday, hitting $4.51. The stock had a trading volume of 126,288 shares, compared to its average volume of 185,178. China SXT Pharmaceuticals has a 12 month low of $2.40 and a 12 month high of $26.96. The business’s 50-day moving average is $3.54 and its 200 day moving average is $4.29.

China SXT Pharmaceuticals Company Profile

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.